SAN FRANCISCO, Jan. 26, 2021 /PRNewswire/ -- Fast, the world's fastest online login and checkout experience, today announced a $102 million Series B funding round led by Addition and Stripe, with ...
-The US FDA grants ONCOS-102 Fast Track designation for PD-1-refractory advanced melanoma -Fast Track designation further strengthens the opportunity for accelerated approval for ONCOS-102 in melanoma ...
SARASOTA, Fla. and NOVATO, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc. (RARE), a biopharmaceutical company focused on the development and ...
- The US FDA grants ONCOS-102 Fast-Track designation for malignant pleural mesothelioma - Fast-Track opens the potential for expedited development and review with the US FDA OSLO, Norway, Feb. 15, ...
OSLO, Norway , June 22, 2021 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage immune-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback